Skip to main content

Table 1 Baseline characteristics of the patients

From: Radiofrequency ablation for pediatric recurrent hepatocellular carcinoma: a single-center experience

Characteristics

n = 10

Age (year) *

11.7 ± 4 (6–17)

Gender (Male/Female)

9/1

Purpose of RFA (Curative/Palliative)

7/3

Hepatitis infection (Yes/No)

8/2

Cirrhosis (Yes/No)

6/4

Primary treatment (Resection/Transplantation)

8/2

Child-Pugh grade (A/B)

9/1

ALBI grade (1/2/3)

6/3/1

ECOG PS score (0/1)

7/3

Biochemical examinations

 

AFP (ug/L)

7961 (2.8-50260)

 ALT (IU/L)

39.1 ± 19 (11–71)

 ALB (g/L)

38.9 ± 7.4 (20-45.1)

 TBIL (µmol/L)

10 ± 3.5 (6.3–16.7)

 PT (s)

12.5 ± 1.4 (10.2–15.3)

 WBC account (×109/L)

5.11 ± 2 (3–10)

 PLT account (×109/L)

152.6 ± 82 (18–306)

Tumor number (Solitary/Multiple)

5/5

  1. * Expressed in mean ± standard deviation (range), or in median (range). RFA: radiofrequency ablation; ALBI: albumin-bilirubin; ECOG PS score: Eastern Cooperative Oncology Group; AFP: alpha-fetoprotein; ALT: alanine aminotransferase; ALB: albumin; TBIL: total bilirubin; PT: prothrombin time; WBC: white blood cell; PLT: platelets